Approval · Notice of Compliance 4222 · 1996
ZITHROMAX: Notice of Compliance 4222
Issued February 21, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4222
- Date
- February 21, 1996
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZITHROMAX | 02212021 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN 250 MG per TAB